Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: Meta-analysis

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1471-1479

  Choi, Hyuck Jae ^a   Ju, Woong ^b,c   Myung, Seung Kwon ^d,e   Kim, Yeol ^d  

^a University of Ulsan   (South Korea)

^b Department of Obstetrics and Gynecology ^*  (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Center for Cancer Prevention and Detection   (South Korea)

^e National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 77954200235     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01532.x     Document Type: Article

References (107)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-6.
2. Ballon SC, Berman ML, Lagasse LD, Petrilli ES, Castaldo TW. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 1981, 57:90-5.
3. Averette HE, Dudan RC, Ford JH. Exploratory celiotomy for surgical staging of cervical cancer. Am J Obstet Gynecol 1972, 113:1090-6.
4. Takeshima N, Yanoh K, Tabata T, Nagai K, Hirai Y, Hasumi K. Assessment of the revised International Federation of Gynecology and obstetrics staging for early invasive squamous cervical cancer. Gynecol Oncol 1999, 74:165-9.
5. Hricak H, Gatsonis C, Chi DS. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005, 23:9329-37.
6. Hopkins MP, Morley GW. Prognostic factors in advanced stage squamous cell cancer of the cervix. Cancer 1993, 72:2389-93.
7. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991, 67:2776-85.
8. Sakuragi N, Satoh C, Takeda N. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999, 85:1547-54.
9. Lai CH, Hong JH, Hsueh S. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 1999, 85:1537-46.
10. Downey GO, Potish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol 1989, 160:1055-61.
11. Potish RA, Twiggs LB, Okagaki T, Prem KA, Adcock LL. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging. Cancer 1985, 56:956-60.
12. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 1980, 9:90-8.
13. Kupets R, Covens A. Is the International Federation of Gynecology and Obstetrics staging system for cervical carcinoma able to predict survival in patients with cervical carcinoma?: an assessment of clinimetric properties. Cancer 2001, 92:796-804.
14. Chung CK, Nahhas WA, Zaino R, Stryker JA, Mortel R. Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol 1981, 12:348-54.
15. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 1997, 278:1096-101.
16. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999, 40:1125-31.
17. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999, 17:41-5.
18. Umesaki N, Tanaka T, Miyama M. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer. Oncol Rep 2000, 7:1261-4.
19. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001, 218:776-82.
20. Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001, 11:263-71.
21. Yeh LS, Hung YC, Shen YY, Kao CH, Lin CC, Lee CC. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep 2002, 9:1289-92.
22. Belhocine T, Thille A, Fridman V. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 2002, 87:90-7.
23. Singh AK, Grigsby PW, Dehdashti F, Herzog TJ, Siegel BA. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:489-93.
24. Ma SY, See LC, Lai CH. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003, 44:1775-83.
25. Tsai C-S, Chang T-C, Lai C-H. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 2004, 58:1506-12.
26. Roh JW, Seo SS, Lee S. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer 2005, 41:2086-92.
27. Park W, Park YJ, Huh SJ. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol 2005, 35:260-4.
28. Wright JD, Dehdashti F, Herzog TJ. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005, 104:2484-91.
29. Unger JB, Ivy JJ, Ramaswamy MR, Charrier A, Connor P. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy. Int J Gynecol Cancer 2005, 15:1060-4.
30. Choi HJ, Roh JW, Seo SS. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006, 106:914-22.
31. Sironi S, Buda A, Picchio M. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006, 238:272-9.
32. Zaspel U, Hamm B. Current relative values of MRI, CT and PET in the diagnosis of cervical carcinoma. Onkologe 2006, 12:854-68.
33. Loft A, Berthelsen AK, Roed H. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007, 106:29-34.
34. Bellomi M, Bonomo G, Landoni F. Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma. Eur Radiol 2005, 15:2469-74.
35. Chung HH, Kang SB, Cho JY. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer? Jpn J Clin Oncol 2007, 37:370-5.
36. Hertel H, Kohler C, Elhawary T, Michels W, Possover M, Schneider A. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol 2002, 87:46-51.
37. Choi HJ, Kim SH, Seo SS. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 2006, 187:W538-43.
38. Sahdev A, Sohaib SA, Wenaden AE, Shepherd JH, Reznek RH. The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 2007, 17:629-36.
39. Vas W, Wolverson M, Freel J, Salimi Z, Sundaram M. Computed tomography in the pretreatment assessment of carcinoma of the cervix. J Comput Tomogr 1985, 9:359-68.
40. Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 1995, 48:119-30. discussion 31-2
41. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993, 13:313-21.
42. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-316.
43. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005, 58:982-90.
44. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.
45. Ishii C, Tada S, Tsukioka M, Tanaka H. [CT diagnosis of uterine cancer]. Gan To Kagaku Ryoho 1982, 9:204-8.
46. Kanehira C, Arai T, Suda Y, Suzuki M. [CT diagnosis and treatment of lymph node metastases from carcinoma of the cervix]. Rinsho Hoshasen 1983, 28:285-92.
47. Kolesnikova EK. Computed tomography in the diagnosis of cervical cancer. Akush Ginekol 1986, 11:18-23.
48. Ono M. Diagnostic values and limits on X-ray computed tomography in untreated uterine cervical cancer. Nippon Igaku Hoshasen Gakkai zasshi. Nippon Acta Radiologica 1986, 46:478-91.
49. Raber G, Luning M, Potzschke B, Natho W. [The place of lymphography and computed tomography in the determination of lymph node status in primary cancer of the cervix]. Radiol Diagn (Berl) 1986, 27:449-59.
50. Zapf S, Halbsguth A, Schweden F. [Problem of pretherapeutic staging of cervical carcinoma. Studies of the diagnostic value of computerized tomography and magnetic resonance tomography in comparison with gynecologic palpation findings and pathologic-anatomic diagnosis]. Geburtshilfe Frauenheilkd 1987, 47:838-42.
51. Kojima Y. [Role of X-ray computed tomography in the staging of cervical carcinoma]. Nippon Sanka Fujinka Gakkai Zasshi 1989, 41:341-8.
52. Raber G, Potzschke B. [The status of computerized tomography in the diagnosis of primary cervix cancer]. Geburtshilfe Frauenheilkd 1989, 49:17-23.
53. Kon Y, Saida Y, Kurosaki Y. [Psoas lymph node metastasis in patients with carcinoma of the uterine cervix]. Nippon Igaku Hoshasen Gakkai Zasshi 1990, 50:1237-42.
54. La Fianza A, Dore R, Di Giulio G. [Lymph node metastasis of carcinoma of the cervix uteri. Role of lymphography and computerized tomography]. Radiol Med (Torino) 1990, 80:486-91.
55. Yamada E. [Role of X-ray computed tomography in the evaluation of prognosis of cervical carcinoma]. Nippon Sanka Fujinka Gakkai Zasshi 1991, 43:205-12.
56. Matsubara M. [Clinical significance of magnetic resonance imaging (MRI) in evaluation of the extension of uterine cervical cancer]. Nippon Sanka Fujinka Gakkai Zasshi 1993, 45:1115-22.
57. Bautz W, Merl T, Kersting-Sommerhoff B. [Computerized tomography staging of carcinomas of the uterus]. Radiologe 1994, 34:370-6.
58. Scheidler J, Heuck A, Reiser M. [MR tomography in staging of carcinomas of the uterus]. Radiologe 1994, 34:377-83.
59. Keskin N, Buyru F, Baysal B, Berkman S. Computed tomographic imaging in the management of cervical cancer. Istanbul Tip Fakultesi Mecmuasi 1996, 59:41-3.
60. Hawighorst H, Knapstein PG, Weikel W. [Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings]. Radiologe 1997, 37:130-8.
61. Heuck A, Scheidler J, Kimmig R. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil]. Rofo 1997, 166:210-4.
62. Kuhnel G, Horn LC, Fischer U. [18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings]. Zentralbl Gynakol 2001, 123:229-35.
63. Michniewicz K, Oellinger J. [Diagnostic imaging in invasive cervical carcinoma: MRI, CT, and ultrasonography]. Zentralbl Gynakol 2001, 123:222-8.
64. Ho CM, Chien TY, Jeng CM, Tsang YM, Shih BY, Chang SC. Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia. J Formos Med Assoc 1992, 91:982-90.
65. Parker LA, McPhail AH, Yankaskas BC, Mauro MA. Computed tomography in the evaluation of clinical stage IB carcinoma of the cervix. Gynecol Oncol 1990, 37:332-4.
66. Ng HT, Chen SL, Wang JC, Sheu MH. Preoperative examination with CT, MRI and comparison of both to histopathologic findings in cervical carcinoma. CME J Gynecol Oncol 1998, 3:256-7.
67. Ozsarlak O, Tjalma W, Schepens E. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol 2003, 13:2338-45.
68. deSouza NM, Dina R, McIndoe GA, Soutter WP. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol Oncol 2006, 102:80-5.
69. Whitley NO, Brenner DE, Francis A. Computed tomographic evaluation of carcinoma of the cervix. Radiology 1982, 142:439-46.
70. Soeters RP, Beningfield SJ, Dehaeck K, Levin W, Bloch B. The value of magnetic resonance imaging in patients with carcinoma of the cervix (a pilot study). Eur J Surg Oncol 1991, 17:119-24.
71. Murmu D, Bhatla N, Bhargava VL. Correlation of radiological and pathological assessment of tumour volume with lymph node involvement in cancer cervix. Indian J Cancer 1998, 35:27-32.
72. Oellinger JJ, Blohmer JU, Michniewicz K. Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol 2000, 122:82-91.
73. Sheu MH, Chang CY, Wang JH, Yen MS. Cervical carcinoma: assessment of parametrial invasion and lymph node metastasis with magnetic resonance imaging. Zhonghua Yi Xue Za Zhi (Taipei) 2000, 63:634-40.
74. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001, 19:3745-9.
75. Ak I, Stokkel MP, Pauwels EK. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 2000, 126:560-74.
76. Kluetz PG, Meltzer CC, Villemagne VL. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000, 3:223-30.
77. Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol 2009, 71:164-74.
78. Zhang C, Chen Y, Xue H. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009, 124:167-73.
79. Liu MT, Hsu JC, Liu WS. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Eur J Cancer Care (Engl) 2008, 17:174-81.
80. Van Nagell JR, Roddick JW, Lowin DM. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges. Am J Obstet Gynecol 1971, 110:973-8.
81. Novakovic P, Mandic A, Vujkov T. Radical hysterectomy for stage IB1 cervical carcinoma: lymph node metastasis as a prognostic factor. J BUON 2002, 7:247-50.
82. Lanciano RM, Corn BW. The role of surgical staging for cervical cancer. Semin Radiat Oncol 1994, 4:46-51.
83. Grumbine FC, Rosenshein NB, Zerhouni EA, Siegelman SS. Abdominopelvic computed tomography in the preoperative evaluation of early cervical cancer. Gynecol Oncol 1981, 12:286-90.
84. Walsh JW, Goplerud DR. Prospective comparison between clinical and CT staging in primary cervical carcinoma. AJR Am J Roentgenol 1981, 137:997-1003.
85. Brenner DE, Whitley NO, Prempree T, Villasanta U. An evaluation of the computed tomographic scanner for the staging of carcinoma of the cervix. Cancer 1982, 50:2323-8.
86. Villasanta U, Whitley NO, Haney PJ, Brenner D. Computed tomography in invasive carcinoma of the cervix: an appraisal. Obstet Gynecol 1983, 62:218-24.
87. van Engelshoven JM, Versteege CW, Ruys JH, de Haan J, Sanches H. Computed tomography in staging untreated patients with cervical cancer. Gynecol Obstet Invest 1984, 18:289-95.
88. Bandy LC, Clarke-Pearson DL, Silverman PM, Creasman WT. Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynecol 1985, 65:73-6.
89. Camilien L, Gordon D, Fruchter RG, Maiman M, Boyce JG. Predictive value of computerized tomography in the presurgical evaluation of primary carcinoma of the cervix. Gynecol Oncol 1988, 30:209-15.
90. Janus CL, Mendelson DS, Moore S, Gendal ES, Dottino P, Brodman M. Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography. Clin Imaging 1989, 13:114-6.
91. Matsukuma K, Tsukamoto N, Matsuyama T, Ono M, Nakano H. Preoperative CT study of lymph nodes in cervical cancer--its correlation with histological findings. Gynecol Oncol 1989, 33:168-71.
92. Kim SH, Choi BI, Lee HP. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 1990, 175:45-51.
93. Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis--a Gynecologic Oncology Group study. Gynecol Oncol 1990, 38:425-30.
94. Kim SH, Choi BI, Han JK. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 1993, 17:633-40.
95. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995, 86:43-50.
96. Chu KK, Chang SD, Chen FP, Soong YK. Laparoscopic surgical staging in cervical cancer - preliminary experience among Chinese. Gynecol Oncol 1997, 64:49-53.
97. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 2000, 175:759-66.
98. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988, 166:623-31.
99. Waggenspack GA, Amparo EG, Hannigan EV. MR imaging of uterine cervical carcinoma. J Comput Assist Tomogr 1988, 12:409-14.
100. Greco A, Mason P, Leung AWL, Dische S, McIndoe GAJ, Anderson MC. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol 1989, 40:401-5.
101. Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol 1994, 49:443-52.
102. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 1994, 190:807-11.
103. Hawighorst H, Schoenberg SO, Knapstein PG. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. J Comput Assist Tomogr 1998, 22:75-81.
104. Yu KK, Hricak H, Subak LL, Zaloudek CJ, Powell CB. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR Am J Roentgenol 1998, 171:707-11.
105. Sheu MH, Chang CY, Wang JH, Yen MS. Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls. Eur Radiol 2001, 11:1828-33.
106. Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr 2004, 28:620-7.
107. Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 2003, 89:73-6.